Evidence map›Paper›PMID 19995921›Full record

ArticleAntimicrobial agents and chemotherapy2010

Development of an allele-specific PCR for detection of the K65R resistance mutation in patients infected with subtype C human immunodeficiency virus type 1.

Thomas A Toni, Bluma G Brenner, Eugene L Asahchop, Michel Ntemgwa, Daniella Moisi, Mark A Wainberg

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thomas A ToniMcGill University AIDS Centre, Department of Medicine, and Lady Davis Institute, Jewish General Hospital, 3755 Cote Ste. Catherine Rd., Montreal, Quebec, Canada H3T 1E2.
Bluma G Brenner
Eugene L Asahchop
Michel Ntemgwa
Daniella Moisi
Mark A Wainberg

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

The selection of drug-resistant variants of human immunodeficiency virus type 1 (HIV-1) is an impediment to the efficiency of antiretroviral (ARV) therapy. We have developed an allele-specific real-time PCR assay to explore the presence of K65R minority species among treated HIV-1 subtype B and C infections. Thirty HIV-1 subtype C- and 26 subtype B-infected patients lacking K65R as determined by conventional sequencing methods were studied, and viral minority species were found in four HIV-1 subtype C samples.

Indexed as

AbacavirAlkynesAllelesAnti-HIV AgentsBenzoxazinesCyclopropanesDideoxynucleosidesDrug Resistance, ViralHIV-1HIV InfectionsHIV Reverse TranscriptaseHumansLamivudineMutationNevirapinePolymerase Chain ReactionAbacavirAlkynesAnti-HIV AgentsBenzoxazinesCyclopropanesDideoxynucleosidesefavirenzHIV Reverse TranscriptaseLamivudineNevirapineZidovudine

Identifiers

PMID19995921
PMCPMC2812128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.